Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence
As global biopharma companies face rising demands for efficiency, standardization, and scientific excellence, Global Capability Centers (GCCs) have emerged as a transformative solution. Our latest whitepaper, "Unlocking the Power of Global Capability Centers (GCCs) in Biopharma: Drive Efficiency, Innovation, and Scientific Excellence," explores how GCCs—especially those based in India—are reshaping how the industry manages scientific…...
Read MoreTop Stories
What’s Next for Global Capability Centers )?
The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025 Decoded: The Medical Affairs Playbook
At the MAPS Americas 2025 conference in New Orleans, one of...
Medical Affairs 2.0: GenAI as the Catalyst for
Digital and AI were hot topics underpinning many of the...
Filter
How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead
The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Preprints, MedRxiv, and Pharma – An Overview
Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...
To Preprint or Not to Preprint: Debate at the 17th Annual ISMPP Meeting
The Covid-19 pandemic has brought with it a deluge of preprints. While timely sharing of...
Digital Therapeutics and Medical Communications: Are We Ready?
Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Artificial Intelligence Is Democratizing Research and There’s More to Come
Today AI technologies are employed to both create and consume research. Scientists across the world...
Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence
The right AI–powered tools and techniques can make a significant difference in how research is...